| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.99B | 8.95B | 8.65B | 9.22B | 9.02B | 9.15B |
| Gross Profit | 5.17B | 5.15B | 5.11B | 5.35B | 5.09B | 5.32B |
| EBITDA | 962.40M | 517.80M | 1.08B | 1.24B | 779.30M | 1.39B |
| Net Income | 158.10M | 25.30M | 598.50M | 663.60M | 200.40M | 952.30M |
Balance Sheet | ||||||
| Total Assets | 11.34B | 11.68B | 11.03B | 11.17B | 11.77B | 12.40B |
| Cash, Cash Equivalents and Short-Term Investments | 592.50M | 701.50M | 748.00M | 707.60M | 550.70M | 1.24B |
| Total Debt | 4.22B | 4.30B | 3.39B | 3.53B | 3.83B | 3.95B |
| Total Liabilities | 6.45B | 6.89B | 5.89B | 6.05B | 6.76B | 7.11B |
| Stockholders Equity | 4.89B | 4.79B | 5.14B | 5.12B | 5.01B | 5.29B |
Cash Flow | ||||||
| Free Cash Flow | 550.50M | 538.40M | 582.20M | 724.70M | -250.90M | 803.30M |
| Operating Cash Flow | 705.30M | 680.40M | 740.90M | 969.40M | 39.20M | 1.07B |
| Investing Cash Flow | -154.40M | -140.10M | -137.70M | -85.10M | -278.20M | -45.00M |
| Financing Cash Flow | -163.40M | -605.70M | -550.40M | -721.80M | -428.20M | -1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $9.11B | 14.93 | 28.33% | 2.58% | 2.61% | 30.39% | |
73 Outperform | $24.59B | 26.77 | 34.77% | 0.93% | 14.63% | 29.96% | |
70 Outperform | $3.40B | 20.66 | 10.26% | 2.18% | 0.54% | -19.72% | |
69 Neutral | $4.32B | 15.58 | 50.10% | 3.36% | 20.78% | 20.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | $3.55B | 22.38 | 3.25% | 0.22% | 3.54% | -55.30% | |
52 Neutral | $6.80B | 26.61 | 15.92% | 1.95% | -0.72% | ― |